About Thomas Luby
Form D filings for March Biosciences in 2024 list Thomas Luby as director.
Thomas Luby first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Thomas Luby in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Thomas Luby works with at each company, as listed on that company's latest Form D.
March Biosciences, Inc. · Form D, Oct 22, 2024
PO
Peter Olagunju
Director
JP
Joseph Petrosino
Director
SH
Sarah Hein
Co-Founder, Chief Executive Officer and director
MM
Maksim Mamonkin
Executive officer and director